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ABSTRACT 21 
Human cerebral microvascular endothelial cells (hCMEC/D3 cell line) form a steady polarized 22 
barrier when cultured in vitro on a permeable membrane. Their susceptibility to enterovirus 23 
(EV) strains was analysed to investigate how these viruses may cross the blood-brain barrier. 24 
A sample of 88 virus strains was selected on phylogenetic features among 44 epidemiologically 25 
relevant types of the four EV species A–D. The EV-A71 genome was replicated at substantial 26 
rates while the infectious virus was released at extremely low but sustained rates at both barrier 27 
sides for at least 4 days. EV-A71 antigens were detected in a limited number of cells. The 28 
properties of the endothelial barrier (structure and permeability) remained intact throughout 29 
infection. The chronic EV-A71 infection was in sharp contrast with the productive infection of 30 
cytolytic EVs (e.g. echoviruses 6 and 30). The hCMEC/D3 barriers infected with the latter EVs 31 
exhibited elevated proportions of apoptotic and necrotic cells, which resulted in major injuries 32 
to the endothelial barriers with dramatic increase of paracellular permeability and virus 33 
crossing to the abluminal side. The following intracellular rearrangements were also seen: early 34 
destruction of the actin cytoskeleton, remodelling of intracellular membranes, and 35 
reorganization of the mitochondrion network in a small cluster near the perinuclear space.  36 
37 
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INTRODUCTION 38 
Enteroviruses (EVs; Picornaviridae) form a large group of non-enveloped enteric viruses, of 39 
which more than 100 different serotypes are human pathogens classified within four taxonomic 40 
species (EV-A to EV-D). Human EVs are transmitted through faecal-oral and respiratory 41 
routes and they actively replicate in the mucosa and epithelial cells of the throat and intestinal 42 
tract. Viral invasion of the intravascular space or viremia may result in spreading to sites such 43 
as the skin, heart and central nervous system (CNS).  44 
The most common clinical manifestation associated with CNS EV infections is aseptic 45 
meningitis. Encephalitis, cerebellitis, myelitis, and poliomyelitis are also observed but less 46 
frequently (Khetsuriani et al., 2006; Antona et al., 2007). There is evidence for hematogenous 47 
and neural routes of poliovirus (PV) dissemination and both involve viremia (Sabin, 1956); the 48 
two routes are not mutually exclusive. By the neural pathway, it is suggested that the virus is 49 
conveyed by retrograde axonal transport from infected tissues to the CNS via peripheral nerves 50 
(Ren & Racaniello, 1992; Gromeier & Wimmer, 1998). In mouse models, PV can be 51 
transported along nerves through either a process involving the CD155 receptor or a receptor-52 
independent manner (Okha et al., 2012). Investigations with different animal models have 53 
revealed a possible link between neurological injury caused by enterovirus A71 (EV-A71) and 54 
retrograde axonal transport of the virus to the CNS (Chen et al., 2007; Khong et al., 2012). The 55 
occurrence of encephalomyelitis and subsequent paralysis associated with these two EVs could 56 
be explained by transport via the neural pathway but the inefficiency of the axonal transport 57 
limits virus access to the CNS (Lancaster & Pfeiffer, 2010).  58 
Alternatively, a virus in the bloodstream may enter the CNS by crossing the vascular 59 
endothelium in the meninges, the choroid plexus, or the brain parenchyma. PV-1 was suggested 60 
to cross the mouse blood-brain barrier (BBB) independently of the CD155 receptor and of 61 
infected leucocytes (Yang et al., 1997). During EV-A71 infection, viremia early after the onset 62 
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of disease was related to severe CNS involvement in young children (Cheng et al., 2014) and 63 
to neurological impairment in experimentally infected rhesus monkeys (Zhang et al., 2011). In 64 
neonates infected with coxsackievirus B3 (CV-B3), a high blood viral load was related to 65 
greater disease severity (Yen et al., 2007). Using sensitive quantitative gene amplification 66 
techniques to amplify viral RNA from the cerebrospinal fluid (CSF), it is possible to detect 67 
evidence of EV infection of the CNS in patients with aseptic meningitis early after the onset of 68 
disease in both children and adults (Volle et al., 2014). Our current knowledge about the 69 
processes involved in EV immigration into the CSF is still limited. As this inflammatory 70 
disease of the subarachnoid space is common to most EV serotypes, it is assumed that viruses 71 
travel through the blood, breaching the blood-CSF barrier either directly or through infected 72 
leukocytes. A number of studies showed that PV, CV-B3, and EV-A71 can infect various 73 
immune cells (Eberle et al., 1995; Vuorinen et al., 1996; Haddad et al., 2004; Wahid et al., 74 
2005a; 2005b; Tabor-Godwin et al., 2010). These data suggest a role of infected leukocytes in 75 
EV dissemination to the CNS through a “Trojan-horse” process. In vitro studies showed the 76 
susceptibility to different EVs of human vascular endothelial cells of different tissue 77 
origins (Conaldi et al., 1997; Ylipaasto et al., 2010; Saijets et al., 2003; Liang et al., 2004; 78 
Zanone et al., 2003; Bozym et al., 2010). In addition, PV-1 and CV-B3 induce different cell 79 
signalling and endocytosis pathways in human brain microvascular endothelial cells 80 
(HBMEC), which is suggestive of possible variations in BBB crossing between EV types 81 
(Bozym et al., 2010; Coyne et al., 2007).  82 
In this study we used the human cerebral microvessel endothelial cell line D3 83 
(hCMEC/D3) as a model of brain endothelium (Weksler et al., 2005; 2013). The hCMEC/D3 84 
cells were used as a model for investigating whether or not EVs can breach an endothelial 85 
barrier. We first examined the susceptibility of hCMEC/D3 cells to infection by a set of 44 EV 86 
serotypes and then analysed the ability of a subset of EVs to cross endothelial barriers. 87 
88 
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RESULTS 89 
Susceptibility of hCMEC/D3 cells to 44 EV types. We used a first set of 88 virus strains 90 
(Table S1) chosen within species B (EV-B; n=37 types), EV-A (n=5), EV-C (n=1), and EV-D 91 
(n=1). Susceptibility of hCMEC/D3 cells to EV strains was assessed in duplicate at 24 h p.i. 92 
by measurement of the production of viral RNA and infectious virus (Fig. S1). The virus yield 93 
exhibited a positive correlation (Spearman’s rho 77%, p-value <0.001) with viral RNA 94 
production (Fig. 1a). The virus strains selected among the EV-B types displayed different 95 
replication patterns defined by two arbitrarily selected thresholds of 0.00 log10 infectious 96 
particles and 3.00 log10 genome copies per cell. The highest infectivity rates (from −0.55 to 97 
2.86 log10 infectious particles per cell and 2.12 to 5.53 log10 genome copies per cell) were 98 
determined for the epidemiologically infrequent types echovirus 1 (E-1) and EV-B69 and the 99 
epidemic types E-6, E-11, E-12, E-13, and E-30. The strains selected among CV-B and EV-A 100 
types displayed the lowest infectivity rates (respectively, from −2.89 to 0.01 and −2.38 to −0.41 101 
log10 infectious particles per cell, and  −0.44 to 3.53 and 2.01 to 4.51 log10 genome copies per 102 
cell).  103 
Kinetics of viral RNA production performed in triplicate for EV-A71, E-6, E-30, and 104 
E-12 strains showed the highest rates of virus replication between 2 and 6 h p.i. (p-value 0.001; 105 
Fig. 1b). Different peaks of viral RNA production were reached at 24 h p.i. among the viruses 106 
tested (mean±SD in log10 copies per cell): EV-A71 (3.29±0.58), E-30 (4.15±0.30), E-6 107 
(5.30±0.25), and E-12 (5.56±0.21). These RNA levels were consistent with those obtained in 108 
Fig. 1a: 2.46±0.63, 3.85±0.26, 5.02±0.15, and 5.46±0.15, respectively.  109 
We determined the number of infected cells at 6 h p.i. (before extensive release of virus 110 
progeny) to investigate whether the variations in susceptibility of hCMEC/D3 cells were 111 
related to differences in the infection efficiencies of EV strains. The infected cells were 112 
numbered in triplicate by computer-assisted image processing of low magnification 113 
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epifluorescence pictures. The highest proportion of infected cells (>30%) was determined for 114 
E-19, EV-B69, and E-1, and intermediate proportions of 10−30% were obtained with E-12 and 115 
E-16 (Fig. 1c). Less than 10% of infected cells were counted for virus strains of various types 116 
(E-30, E-3, E-7, CV-B6, E-4, E-14, E-18, EV-A71, E-9, E-32, CV-B3, and E-25). About 20 117 
infected cells per cm² were counted for E-27 and E-11, and only 3−5 infected cells per cm² for 118 
EV-B70, EV-B77, CV-A9, E-15, E-24, and E-26 (data not shown). Two E-6 and E-13 strains 119 
exhibited different infection efficiencies (E-6/CF2660-01 >30%; E-6/CF158061-11 and E-120 
13/CF1275-00 10−30%; E-13/CF1925-01 <10%). The overall data suggest variations in the 121 
susceptibility of the hCMEC/D3 cells to infection by different EV types and subtypes. 122 
 123 
Cell mortality during virus infection and multidimensional analysis of EV infectivity. The 124 
mortality rates of infected hCMEC/D3 cells were determined in quadruplicate at 24 h p.i. for a 125 
subset of 15 EV strains representative of different susceptibility patterns determined above in 126 
hCMEC/D3 cells (Fig. 1d). The mortality threshold was defined by the highest value of the 127 
standard deviation calculated with mock infected cells (i.e. 10%). High cell mortality rates 128 
>50% were found with E-1 and EV-B69, and cell death resulted from both necrosis and 129 
apoptosis. Intermediate cell mortality rates between 40 to 50% were estimated for E-12, E-130 
6/CF2660-01, and E-30/CF282-97. Other virus strains of the two latter types caused lower cell 131 
mortality (30−40%). Two E-13 strains were related to different cell mortality rates (CF1274-132 
00, 38.3%; CF1925-01, <30%). Mortality of cells infected with EV-A71 (11%) was similar to 133 
that of mock infected cells.  134 
We used principal component analysis (PCA) to visualize on a map the ordination of 135 
the 15 EV strains according to the proportion of infected cells, the production of viral genomes, 136 
the yield of infectious particle production, and cell mortality rates (Fig. S2). The proportion of 137 
infected cells and cell mortality exhibited a positive correlation, hereafter designated cell 138 
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sensitivity (x-axis). The productions of viral genomes and infectious virus were positively 139 
correlated and designated as viral replication (y-axis). As cell sensitivity and viral replication 140 
were orthogonal, they were not correlated with each other. PCA confirmed that the hCMEC/D3 141 
cell line displayed large differences in sensitivity to EV types and strains within the same type 142 
(Fig. 2). We selected viral strains representative of different PCA patterns for further 143 
investigations with endothelial barriers (Table S2). 144 
 145 
Variations in permeability and structural integrity of endothelial barriers among EV 146 
types. We prepared endothelial barriers in vitro with the hCMEC/D3 cells (see Fig. S3) and 147 
quantified infection with five EV types so that infection and paracellular permeability were 148 
assessed in the same samples. The structural features of mock-infected endothelial monolayers 149 
and their restrictive permeability were analysed with transmission electron microscopy (TEM) 150 
and clearance of a non-permeable fluorescent compound (Figs. S3 and S4). Endothelial 151 
barriers infected with E-6, E-11, E-12, and E-30 strains exhibited little change in paracellular 152 
permeability at 24 h p.i. but permeability progressively increased afterwards (Fig. 3a−3d). A 153 
release of viral genomes (>6 log10 copies) was detected at 6 h p.i. at both barrier sides, but in 154 
the abluminal compartment, viruses were detectable below the titration threshold for E-12 and 155 
E-30. The release of infectious progeny reached highest levels at 24−48 h p.i. Scanning electron 156 
microscopy (SEM) allowed the identification of three main cytological alterations (Fig. 4). 157 
Compared to mock infected controls, which had the appearance of joined cobblestones (Fig. 158 
4a−4c), the infected endothelial barriers exhibited cells with structural features suggestive of 159 
necrosis (damage plasma membrane) and apoptosis (preserved and budded plasma membrane), 160 
indicated, respectively, by red and green arrow heads in Fig. 4d−4l. Rounded cells without 161 
apparent altered plasma membrane were suggestive of early steps of cell death (see blue arrow 162 
heads). On the basis of these analyses, we found evidence of large amounts of altered cells, 163 
 8
which caused breaches within endothelial barriers, as indicated by the visualization of pores of 164 
the microporous membrane (white arrow heads). 165 
The paracellular permeability of endothelial barriers infected with the EV-A71 strains 166 
(genogroups C1 and C2) was maintained at levels similar to those of mock-infected barriers 167 
until 96 h p.i. (Fig. 3e and 3f). The abluminal release of EV-A71 genomes and infectious virus 168 
was highest at 24 h p.i. and remained constant at slightly lower levels up to 96 h p.i. The 169 
infectious progeny was below the titration threshold at the abluminal side after 24 h p.i., but 170 
was consistently determined at low levels at the luminal side. SEM observations showed few 171 
groups of infected cells and a limited number of small breaches (Fig. 4m−4o). 172 
 173 
Intracellular changes in endothelial barriers during EV infection. The endothelial barriers 174 
were analysed by TEM to visualize the intracellular features of infected hCMEC/D3 cells and 175 
to investigate variations between EV types. The altered cells of endothelial barriers infected 176 
with the E-6/CF2660-01 strain displayed features indicative of virus infection, which were 177 
similar to those caused by E-30 and E-12 (data not shown). At 24 h p.i., the impaired cells 178 
displayed shrunken nuclei relocated near the cell membrane and contained myriads of virus-179 
induced vesicle-like membranous structures, 200 nm in diameter (Fig. 5a and 5b). These 180 
structures had either single or double membranes and were organized in extensive intracellular 181 
arrangements (Fig. 5c). Some infected cells showed evidence of tubular structures with 182 
positive membrane invagination that enclosed cytoplasmic components (Fig. 5d). Clusters of 183 
electron-dense granules between membranous structures were suggestive of viral particles 184 
(Fig. 5e). Mitochondria were grouped near the membranous structures, which contrasted with 185 
mock-infected cells, in which mitochondria formed an extensive network (Fig. S4). Large 186 
single-membrane vesicles (600−1000 nm in diameter) contained electron-dense cytoplasmic 187 
material and multilamellar structures resembling autophagic vacuoles (Fig. 5c). 188 
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In contrast to the features described above, the impaired cells of endothelial barriers 189 
infected with EV-A71/CF166105-10 displayed a number of structural variations. As shown in 190 
Fig. 6a–6d, the EV-A71 infected cells maintained an elongated shape and contained nuclei 191 
similar in shape to those seen in control barriers. Remodelling of intracellular components 192 
included vesicle-like structures and mitochondria clustered near the nucleus whereas EV-A71-193 
induced membranous structures had a uniform round shape with a diameter of 500 nm and a 194 
multilamelar structure (Fig. 6e–6i). 195 
 196 
Intracellular injury patterns common to EV types. The early virus-induced intracellular 197 
injuries at 6 h p.i. were further analysed by confocal microscopy and viral replication was 198 
detected by staining the VP1 protein. The infected cells displayed major reduction in staining 199 
of polymerized actin in comparison to controls (Fig. 7a−7r vs Fig. 7s−7u). This indicates 200 
effective cytoskeleton impairment early after the initiation of viral protein synthesis and would 201 
explain the subsequent cell rounding. 202 
Early virus-induced changes in the mitochondrion network were analysed with a 203 
fluorescent probe that accumulates in active mitochondria. Mitochondria were stained in all 204 
virus-infected cells (Fig. 8a−8o) but, in contrast to mock-infected controls, they were clustered 205 
in a perinuclear area (Fig. 8p−8r). Rearrangement of the mitochondrion network was marked 206 
in cells exhibiting prominent staining of the VP1 protein at 6 h p.i. (see white arrowheads). 207 
Cells with reduced VP1 staining exhibited no or minor changes in the mitochondrion network 208 
(see yellow arrowheads). Mitochondrion clustering was dependent on viral replication 209 
intensity but was not directly related to cell rounding, since cells that were not yet round were 210 
also displaying clustered mitochondria.  211 
212 
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DISCUSSION 213 
Human EV infections are associated with meningitis, encephalitis, and encephalomyelitis but 214 
our current knowledge about CNS invasion by enteric viruses is still scant. The BBB may 215 
represent a common entry pathway for EVs during viremia, which precedes disease onset. In 216 
this study, we used the human cerebral microvascular endothelial cell line hCMEC/D3 as a 217 
model system for investigating EV entry routes into the CNS through the human BBB. We 218 
showed that the hCMEC/D3 cells were permissive to infection by a large array of EVs and 219 
found major differences between types and genogroups. Most EV strains occupied a central 220 
position in the susceptibility spectrum of hCMEC/D3 cells, notably the E-6, E-13, and E-30 221 
strains, and intratypic variations may be related to individual genetic differences among 222 
genogroups and subgenogroups. A wide range of cellular receptors has been observed in 223 
human EVs (reviewed in Merilahti et al., 2012). Although we did not examine the binding 224 
processes of EVs to the hCMEC/D3 cell surface, there is a large body of earlier experimental 225 
evidence to suggest that the intertypic variations in hCMEC/D3 susceptibility to EVs can be 226 
attributed to their propensity for using a wide range of receptors and internalization processes 227 
(Ylipaasto et al., 2010; Coyne et al., 2007; Bozym et al., 2010). For instance, E-1 stands apart 228 
within the susceptibility spectrum of hCMEC/D3 cells to EV infection, a pattern which may 229 
be related to the fact that it is the only type known to bind integrin α2β1 (Bergelson et al., 230 
1993). A number of EV types examined in our study (E-6, E-11, E-12, E-13, and E-30) bind 231 
the same cellular receptor CD55 (Bergelson et al., 1995). Yet, the virus strains of these types 232 
did not cluster in the same area of the susceptibility spectrum of hCMEC/D3 cells. This 233 
suggests that additional factors other than canonical receptors should be considered and that 234 
genogroup features may be involved.  235 
Our investigation provides evidence of two major clusters among EV types. A first 236 
cluster consists of the EVs that exhibit a highly cytolytic phenotype, produce infectious 237 
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progeny, and induce extensive disruption of the endothelial barrier. Early during cellular 238 
infection by these viruses, the amount of virus genomes released in the abluminal compartment 239 
was >10,000 times higher than that of infectious progeny. We assumed that paracellular 240 
transport of viral RNA and defective virus particles was not involved because barrier 241 
permeability to the fluorescent reporter was not yet compromised at this time, a hypothesis that 242 
is also supported by SEM observations. At 24 h p.i., the difference between the release of viral 243 
genomes and virus particles was substantially reduced at the abluminal side as a result of the 244 
destruction of the endothelial barrier caused by infected dying cells. In contrast, the release of 245 
genomic material was relatively constant over time at the luminal sides. Accordingly, massive 246 
amounts of viral genomes appeared to drain off the cells through their basolateral membrane 247 
early during infection by a yet unknown process.  248 
The second cluster comprises CV-B and EV-A71 types, which produced no impairment 249 
of the in vitro model of endothelium barrier. A key observation, in sharp contrast with the 250 
above data, is that hCMEC/D3 cells are moderately permissive to EV-A71 infection. This 251 
pattern resulted from a high replication rate of the viral genome but a remarkably poor 252 
production of infectious viruses. Both the virus and viral RNA were released from the luminal 253 
and basolateral sides of the endothelial barrier but at disproportionately different rates as the 254 
infectious virus was consistently detected at minute amounts. This process was maintained for 255 
at least 4 days and did not induce a breakdown of the barrier nor changed the paracellular 256 
permeability as measured with the LY surrogate marker. This non-disruptive pattern occurred 257 
even when the barriers were inoculated with a MOI of about 100 TCID50 per cell (data not 258 
shown), which suggests that it was not dependent on the initial infection conditions but was 259 
more probably related to post-entry factors. A non-disruptive and long-term replication pattern 260 
was also shown for CV-B3 and CV-B5 (data not shown). A persistent replication was reported 261 
earlier for CV-B3 and CV-B4 in human dermal microvascular endothelial cells (Zanone et al., 262 
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2003). A flavivirus West Nile virus can cross in vitro BBB models by infection of endothelial 263 
cells (Verma et al., 2009). The brain endothelium crossing and infection by West Nile virus is 264 
not related to direct disturbance of the endothelial barrier integrity in vitro, as observed in our 265 
study for EV-A71 and CV-B. The loss of BBB integrity associated with the West Nile virus 266 
may be related to up regulation of cell adhesion molecules (e.g. VCAM-I, E-Selectin) in 267 
infected endothelial cells, thus promoting trans endothelial migration of leucocytes in vivo 268 
(Verma et al., 2009; 2010). 269 
The infected cells showed typical ultrastructural features of a picornavirus infection. 270 
We found evidence for both apoptosis and necrosis among infected cells regardless of the EV 271 
type, in agreement with data indicating a competition between cell death pathways and 272 
picornavirus replication (Agol & Gmyl, 2010). We also observed disruption of the actin 273 
cytoskeleton network and that of intercellular junctions as evidenced by the rounding of 274 
infected cells. The actin cytoskeleton has an important role in the maintenance of stable inter 275 
endothelial junctions and prevents paracellular transport to the brain (Stamatovic et al., 2012; 276 
Spindler & Hsu, 2012). Remodelling of intracellular membranes was the third hallmark of a 277 
picornavirus infection seen in infected hCMEC/D3 cells but discrete variations occurred 278 
between echoviruses (E-6, E-12, and E-30) and EV-A71. In the echovirus infections, we found 279 
evidence of single and double membrane vesicles organized in compact arrangements near the 280 
nucleus and of structures that displayed positive membrane invagination. Both features were 281 
reported earlier in Vero and Hela cells infected by CV-B3 and PV-1, respectively (Limpens et 282 
al., 2011; Belov et al., 2012). The vesicular structure in the EV-A71 infected hCMEC/D3 cells 283 
was characterised by less condensed vesicles and an increased proportion of multilamellar and 284 
large vesicles. Finally, our analyses with TEM and fluorescence microscopy showed clustering 285 
of the mitochondrion network, a previously unobserved feature of EV infections that occurred 286 
early during the virus infection and whose origin is still unclear. It may be related to virus-287 
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induced disruption of microtubules, as suggested for cells infected with the hepatitis B virus 288 
(Kim et al., 2007). A similar feature was also reported for African swine fever virus, another 289 
DNA virus, and was related to coupling between viral translation and ATP synthesis (Rojo et 290 
al., 1998).  291 
The most frequent EV infections of the CNS cause meningitis as a result of virus 292 
replication in the cells of the leptomeninges, the brain coverings (Rotbart, 1995). These 293 
infections are usually self-limited because the meninges are directly accessible to immunologic 294 
surveillance and subject to rapid immune responses (Engelhardt & Coisne, 2011). The varying 295 
amounts of viruses in the CSF of patients with EV meningitis within few hours after the onset 296 
of symptoms (Volle et al., 2014) may reflect virus unloading from these infected sites. The 297 
meningeal blood vessels, which form the barrier between blood and CSF, are only made of 298 
non-fenestrated endothelial cells; this contrasts with the BBB, which includes other cell types. 299 
Accordingly, our endothelium model is consistent with the blood-CSF barrier. The infection 300 
of endothelial cells reported in this study for a large array of EV types may occur during the 301 
earliest stages of viremia, which develops following EV replication in peripheral tissues. The 302 
local EV replication may contribute to infection of leptomeninges and development of a neuro-303 
inflammatory disease. Of note, regional blood flow reduction and cerebral vasculitis can be 304 
observed in children with E-30 aseptic meningitis (Nishikawa et al., 2000). Care must be taken 305 
in making generalised conclusions of pathophysiology based on in vitro model systems and 306 
the transcellular passage for neural spread of EVs requires close examination in an appropriate 307 
in vivo model.  308 
309 
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MATERIALS AND METHODS 310 
Cell lines and viruses. HCMECs were grown in EBM-2 basal medium (Lonza) supplemented 311 
with 5% fetal bovine serum (FBS), 1% penicillin (10,000U), 1% streptomycin (10mg/ml; GE 312 
Healthcare Life Science), 1% chemically defined lipid concentrate (Invitrogen), 10 mM of 313 
HEPES, 1.4 μM of hydrocortisone (Sigma Aldrich), 1.5 μg×ml-1 of ascorbic acid (Sigma 314 
Aldrich), and 200 ng×ml-1 of basal fibroblast growth factor (Sigma Aldrich). The cells were 315 
seeded for all experiments on rat collagen I-coated culture surfaces (RD-System). The 316 
rabdomyosarcoma (RD) cells were grown in RPMI 1640 medium (Lonza) with 1% 317 
penicillin/streptomycin, and 4% FBS. The buccal epithelial carcinoma (KB) cells were grown 318 
in DMEM basal medium (GE Healthcare Life Science) with 1% penicillin/streptomycin, and 319 
6% FBS. All cell cultures were maintained at 37°C in a humidified atmosphere containing 5% 320 
CO2. 321 
A sample of 88 EV strains, comprising 23 reference strains and 65 clinical isolates, 322 
recovered from patient specimens (CSF, stool or throat) was used in the study (Table S1). 323 
Virus stocks were prepared with KB (coxsackievirus B) and RD cells (other EVs) and stored 324 
at −20°C. Titration of viral suspensions was done using our end point dilution assay (Bailly et 325 
al., 1991). The cell cultures were inoculated at a multiplicity of infection (MOI) of 5 for 1 h at 326 
37°C in all experiments; after washing with PBS, they were incubated for the indicated times. 327 
Extraction of nucleic acids and EV real-time RT-qPCR. Nucleic acids were extracted from 328 
200 µl from supernatants or the whole cells and supernatant using the NucliSens®EasyMAG™ 329 
extractor (bioMérieux) and were eluted with 25 µl of the elution buffer provided by the 330 
manufacturer. A previously described competitive internal control was added during the 331 
extraction step and amplified in our in-house RT-qPCR assay (Volle et al., 2012). 332 
Viability of infected hCMEC/D3 cells. Cells were infected separately by 15 EV strains. After 333 
two washes at 24 h p.i., the cells were detached, centrifuged for 10 min at 1000g, stained with 334 
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the Apoptotic/Necrotic/Healthy Cells Detection Kit (Promokine), and analysed by flow 335 
cytometry (BD-LSRII, BD Bioscience). Cells were considered as being viable when only 336 
stained with the Hoechst compound, apoptotic when only stained with the Annexin V 337 
conjugated antibody, or necrotic when they were stained with both Annexin V and ethidium 338 
homodimere III. Cell fragments were detected through ethidium homodimere III staining 339 
alone.  340 
Fluorescent microscopy. HCMEC/D3 cells were grown in chamber slides, infected for 6 341 
hours by different EV strains, and fixed with 4% paraformaldehyde for 10 min. For 342 
mitochondria staining, the cells were incubated at 37°C for 1 h before fixation, with complete 343 
EBM-2 medium containing 50 nM of MitoTracker® Mitochondrion-Selective probe M7510 344 
(Invitrogen) in a humidified atmosphere of 5% CO2. Cells were permeabilized with 0.5% 345 
Triton X100 in PBS for 5 min, saturated for 10 min with 5% BSA in PBS, and incubated 346 
overnight at 4°C with mouse primary monoclonal antibodies against the EV capsid protein 347 
VP1 (Diagnostic Hybrid). After three PBS washes, incubation was pursued for 1 h at 37°C in 348 
a solution of anti-mouse secondary antibodies conjugated to Dyelight488 (Anticorps enligne). 349 
In the tests for which active mitochondria staining was not required, red-phalloïdin used for 350 
actin staining was included in the secondary antibody solution. After three PBS washes, nuclear 351 
DNA was counterstained with a Hoechst solution (Promokine). The slides were mounted with 352 
coverslips and observed with an epifluorescence microscope (Olympus BX41) or scanning 353 
confocal microscope (LSM 510, Carl Zeiss MicroImaging Inc.). Automated image analysis 354 
(FIJI software) was used to calculate the number of infected cells.  355 
EV crossing through an in vitro model of brain microvascular endothelial barrier. To 356 
obtain microvascular endothelial barriers, hCMEC/D3 cells were cultured on a permeable 357 
membrane (0.4 μm pore) placed in the upper chamber of a Transwell device (12-well plate, 358 
Corning). The upper chamber was seeded with 40,000 cells/cm² and incubated for 5 to 7 days 359 
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to obtain a tight confluent cell monolayer. In this in vitro model, the cells are polarized and 360 
display a luminal side and an abluminal side (Weksler et al., 2005). The luminal sides of non-361 
permeable barriers were exposed separately to various EV strains, the infected barriers were 362 
incubated for the indicated times, and permeability was determined at each time p.i. (see 363 
below). The yield of infectious particles and the total amount of viral genome released through 364 
the abluminal and luminal sides were determined as described above. 365 
Lucifer Yellow permeability assay. The paracellular seal of the endothelial barrier was 366 
determined in triplicate by testing the permeability to the Lucifer Yellow marker (LY, Sigma). 367 
The cell monolayers were washed twice with collecting buffer consisting of HBSS (GE 368 
Healthcare Life Science) supplemented with 1% of HEPES (GE Healthcare Life Science) and 369 
1% of sodium pyruvate (GE Healthcare Life Science).  The LY marker (50 µM; 400 µl) was 370 
added to the upper chamber. Cells were incubated at 37°C (5% CO2 and 100% humidity) in 371 
three successive collecting wells, each containing 1.6 ml of collecting buffer, for respectively 372 
10, 15, and 20 min. The LY concentration in the collecting buffer of each well and the stock 373 
LY solution were determined by fluorometry. Parallel negative control tests were performed 374 
with cell-free collagen-coated culture membranes. Samples were analysed in black 96-well 375 
microtiter plates using a Fluoroskan Ascent FL fluorometer (Thermo Electron Corporation, 376 
France) at 485 and 538 nm wavelengths for excitation and emission, respectively.  377 
Scanning and transmission electron microscopy (SEM and TEM). The endothelial barriers 378 
were washed with 0.2M Na cacodylate buffer (NCB; pH 7.4) and fixed overnight at 4°C in 379 
1.6% glutaraldehyde-NCB. The cells were fixed for 1 h with 1% OsO4 in NCB. For SEM 380 
preparation, cells were dehydrated in graded ethanol, followed by critical point drying with 381 
100% ethanol and hexamethyldisilasane (1:1) for 10 min, sputter-coated with gold (JEOL JFC-382 
1300), and observed at 5kV with a JEOL 6060-LV microscope. For TEM preparation, cells 383 
were dehydrated in graded ethanol, infiltrated sequentially with three mixtures of 384 
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ethanol/EPON resin (2:1, 1:1, and 1:2) for 1 h each, embedded in EPON resin overnight at 385 
room temperature, and cured 2 days in a 60°C oven. Thin sections (70 nm, UC6 386 
ultramicrotome, Leica) were stained with uranyl acetate and Pb citrate, and observed at 80 kV 387 
with a Hitachi H-7650 microscope. All chemical products were provided by Delta 388 
Microscopies. 389 
Statistical Analysis. Statistical analyses were made with software Stata (version 12, 390 
StataCorp, College Station, US). Tests were two-sided, with a type I error set at a=0.05. 391 
Quantitative data are expressed as means (and associated standard deviation, Gaussian 392 
distribution verified by the Shapiro-Wilk test). Correlated data were analysed by mixed models 393 
to study the evolution of parameters taking into account between and within strain variability 394 
(random effects such as intercept and slope). These analyses were completed by ANOVA for 395 
repeated measures followed by post-hoc Tukey-Kramer test. Principal component analysis was 396 
done to explore the relation between several quantitative parameters. Correlation coefficients 397 
(Pearson or Spearman when appropriate) were calculated to quantify these relations. 398 
399 
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LEGENDS TO FIGURES  400 
Fig. 1. Heterogeneity of enterovirus infection in hCMEC/D3 cells. Replication in 401 
hCMEC/D3 cells of EV strains selected among species, types, and genogroups was examined 402 
at 24 h p.i. (a) Data are represented as means of two independent assays and given as the 403 
number of viral genome copies per cell (x-axis) and of infectious particles per cell (y-axis). 404 
Correlation between the yield of virus genome and yield of infectious virus is indicated. (b) 405 
Replication kinetics of virus strains of four EV types in hCMEC/D3 cells. Data are 406 
representative of means of three independent replicates for each virus E-30 (●), E-6 (▲), E-12 407 
(♦), and EV-A71 (×). (c) Susceptibility spectrum of the hCMEC/D3 cell line to EVs estimated 408 
as the proportion of infected cells at 6 h p.i. A sample of 24 viral strains representing 19 409 
different types was tested. Green and blue fluorescence indicate the VP1 protein and the nuclei, 410 
respectively. Scale bar, 100 µm. Data are represented as mean ± SD of three experiments. (d) 411 
Comparison of cell mortality rates at 24 h p.i. (n=15 EV strains). Data are represented as mean 412 
± SD of four independent experiments. The blue line indicates the cell mortality rate (10%) in 413 
mock-infected cells (NoV). 414 
 415 
Fig. 2. Principal component analysis of enterovirus replication in hCMEC/D3 cells. 416 
Ordination of the data obtained for 15 EV strains using principal component analysis. The 417 
horizontal axis is linked to cell sensitivity to EVs and the vertical axis to virus production.  418 
 419 
Fig. 3. Disruption of a microvascular endothelial barrier during enterovirus infection. 420 
Endothelial barriers of hCMEC/D3 cells produced on Transwell® membranes were infected 421 
with E-6/CF2660-01 (a), E-11/CF228046-07 (b), E-12/CF1157-91 (c), E-30/CF2575-00 (d), 422 
EV-71/CF166105-10 (e), and EV-A71/CF160019-10 (f). At the indicated time points, the 423 
culture mediums in the luminal and abluminal compartments were collected and stored 424 
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separately. Paracellular permeability was measured. Data are indicated as mean ± SD of three 425 
experiments. The number of EV genome copies and infectious virus particles are respectively 426 
indicated with white and light grey bars for the luminal compartment, and respectively with 427 
dark grey and dashed bars for the abluminal compartment. Permeability coefficients for mock 428 
infected and infected barriers are indicated with green and red lines, respectively.  429 
 430 
Fig. 4. Disruption of endothelial barriers during enterovirus infection. The hCMEC/D3 431 
barriers were analysed with SEM at 24 h p.i. Representative fields of duplicate experiments 432 
are shown: mock-infected monolayers (a–c), and barriers infected with E-6/CF2660-01 (d–f), 433 
E-12/CF1157-91 (g–i), E-30/CF2575-00 (j–l), and EV-A71/CF166105-10 (m–o). White arrow 434 
head, breach of the endothelial barriers; red and green arrow heads, cells with a necrotic and 435 
an apoptotic shape, respectively; blue arrow head, round cell with no sign of altered plasma 436 
membrane.  437 
 438 
Fig. 5. Ultrastructural features at 24 h p.i. of hCMEC/D3 barriers infected with an E-6 439 
strain. The infected hCMEC/D3 barriers were observed at low magnification with TEM (a and 440 
b). Virus-induced reorganization of cytoplasmic elements (c). Features of the vesicular 441 
structures (d). Dense electron punctuation suggestive of virus aggregates (e). Bars, 4 µm (a and 442 
b); 500 nm (c–e). Representative fields of duplicate experiments are shown; mock-infected 443 
cells are shown in figure S4. Abbreviations: N, nucleus; M, mitochondria; MC, membranous 444 
replication complex; A, autolysosome/amphisome; V, virus aggregates.  445 
 446 
Fig. 6. Ultrastructural features at 24 h p.i. of hCMEC/D3 barriers infected with an EV-447 
A71 strain. The infected hCMEC/D3 barriers were analysed at low magnification with TEM; 448 
unaltered cells (a and b) and altered cells with virus-induced vesicular structures (c and d). 449 
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Features of the vesicular structures (e–i). Bar, 10 µm (a–d); 1 µm (e and f); 500 nm (g–i). 450 
Representative fields of duplicate experiments are shown; mock-infected cells are shown in 451 
figure S4. Abbreviations: N, nucleus; M, mitochondria; MC, membranous replication complex.  452 
 453 
Fig. 7. The actin cytoskeleton network is disrupted in enterovirus-infected hCMEC/D3 454 
cells. The hCMEC/D3 cells were analysed at 6 h p.i. during replication of strains E-12/CF1157-455 
91 (a−c), E-6/CF2660-01 (d−i), E-30/CF2575-00 (j–l), E-11/CF228046-07 (m–o), and EV-456 
A71/CF166105-10 (p–r); mock-infected cells (s–u). Actin network is shown in red, VP1 capsid 457 
protein in green, and nuclei in blue. Bars represent 10 µm. White arrow heads indicate 458 
intermediate disruption of actin cytoskeleton. 459 
 460 
Fig. 8. Perinuclear relocation of active mitochondria in enterovirus-infected hCMEC/D3 461 
cells. The hCMEC/D3 cells were analysed at 6 h p.i. during replication of E-12/CF1157-91 462 
(a−c), E-6/CF2660-01 (d−f), E-30/CF2575-00 (g–i), E-11/CF228046-07 (j–l), and EV-463 
A71/CF166105-10 (m–o); mock-infected cells (s–u). Active mitochondria are shown in red, 464 
VP1 capsid protein in green, and nuclei in blue. Bars represent 10 µm. White and yellow arrow 465 
heads indicate dense clusters and intermediate clustering of mitochondria, respectively. 466 
467 
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Fig. S1. Schematic representation of the strategy used for testing the susceptibility of 
hCMEC/D3 cells to a large array of enterovirus types. Virus production per cell was 
assessed in hCMEC/D3 cells cultured in 96-wells plates. A total of 88 different EV strains 
were tested in two independent replicates. The whole cell monolayers and supernatants were 
harvested at 24 h p.i. The amount of viral genomes and infectious particles were quantified by 
RT-qPCR and viral titration respectively. Cell mortality was analysed during virus infection 
of hCMEC/D3 cells cultured in 12-well plates; 15 EV strains were compared in 4 independent 
replicates. Cells were collected, stained for apoptosis and necrosis testing, and counted by 
flow cytometry at 24 h p.i. Infection efficiency was assessed in cells cultured in 8-well 
labtek® culture slides. The hCMEC/D3 cells were inoculated with 50 different EV strains. At 
6 h p.i., before massive release of progeny viruses, cells were fixed, immunostained for viral 
protein VP1 and nuclear DNA, and observed at low magnification (10X) with an 
epifluorescence microscope. The pictures were then analysed to determine the proportion of 
infected cells.  
 
Figure S2 
 
 
 
 
 
Fig. S2. Correlation circle of the principal component analysis showing the variables 
linked with horizontal and vertical axis. 
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Fig. S3. In vitro model of brain endothelial barrier of polarized hCMEC/D3. 
Schematic representation of the model of a blood-brain endothelial barrier obtained by culture of 
hCMEC/D3 cells at the surface of a permeable membrane (0.4 μm pore; coated with rat collagen-I) 
included within the upper chamber of a Transwell device (a). Lucifer yellow (LY) paracellular 
permeability was measured for 11 days after seeding cells in different independent experiments 
representative of triplicate cultures (b). Transverse observations by transmission electron microscopy 
of a polarized hCMEC/D3 cell monolayer (culture of 7 days), scale bar 2 µm (c). Intercellular 
junction, scale bar 200 nm (d), with a high magnification showing an electron-dense tight junction, 
with the measurements of intercellular spaces, scale bar 100 nm (e). 
Figure S4 
 
 
Fig. S4. Ultrastructural features of mock infected cells of an in vitro model of blood-
brain endothelial barrier. 
Low-magnification transmission electron micrograph of 7-day hCMEC/D3 monolayers (a and 
b). Confocal observation of mitochondria network (red) in hCMEC/D3 cells (c), High 
magnification transmission electron micrograph of 7-days cultures hCMEC/D3 monolayer. A 
central nucleus is surrounded by plenty of mitochondria near the rough endoplasmic reticulum 
(d). Bars represent, 10 µm (a ‒ c); 5 µm (d). N, nucleus; M, mitochondria; ER, endoplasmic 
reticulum.  
Species Serotypes Strains Isolation source Clinical manifestations
CF192073-11 Throat Encephalitis
CF197013-11 Feces Guillain Barre
CF308011-10 Throat Hand-Foot and Mouth disease
CF063006-11 Feces Fever
CV-A5 CF193056-11 Feces Acute meningitis
CV-A6 CF218013-10 Throat Hand-Foot and Mouth disease
CF605-00 Feces Septic shock
CF166105-10 Throat Hand-Foot and Mouth disease
CF160019-10 Throat Hand-Foot and Mouth disease
CV-A9 CF027040-07 Throat Acute meningitis
CF741-93 Feces
CF217010-08 Feces
CF314051-04 Throat
CF186019-07 Throat Acute meningitis
NANCY Stools Minor febril illness
CF183076-08 Throat Acute meningitis
CF193061-05 Throat Acute meningitis
CV-B4 CF169091-07 Throat Acute meningitis
CF516-00 CSF Headache; Fever; Vomiting
CF186106-05 Throat Acute meningitis
CF202076-06 Throat Acute meningitis
SCHMITT Stools None
CF132-87
E1 FAROUK Stools None
CORNELIS Stools Acute meningitis
CF307001-05 Feces Acute meningitis suspected
MORRISSEY Stools Acute meningitis
CF180108-05 Throat
DUTOIT
CF248076-05 Feces
CF101013-08 Feces Acute meningitis
E5 NOYCE Stools Acute meningitis
CF990-00 CSF Acute meningitis
CF2660-01 CSF Acute meningitis
CF1057-00 CSF Acute meningitis
CF328087-03 Throat Acute meningitis
CF671-00 CSF Acute meningitis
CF1634-01 CSF Acute meningitis
CF1679-02 CSF Acute meningitis
CF158061-11 Throat
CF185010-11 Throat Acute meningitis
WALLACE Stools None
CF185103-05 Throat Acute meningitis
E9 CF293042-06 Throat Acute meningitis
CF22-80
CF1462-00 CSF Acute meningitis
CF228046-07 Throat Acute meningitis suspected
E12 CF1157-91
DELCARMEN Stools None
CF1083-91
CF1274-00 CSF Acute meningitis
CF1925-01 CSF Acute meningitis
CF1393-00 CSF Acute meningitis
CF1901-00 Throat Acute meningitis
CF282003-06 Throat Acute meningitis
TOW Stools Acute meningitis
CF225059-08 Feces
E15 CHARLESTON Stools None
E16 CF187056-09 Feces Acute meningitis
E17 CF596-78
METCALF Stools Diarrhea
CF279084-05 Throat Acute meningitis
TR115015-05
E19 BURKE Stools Diarrhea
E20 JV1 Stools Fever
E21 FARINA Stools Acute meningitis
E24 DECAMP Stools Diarrhea
JV4 Stools Diarrhea
CF205083-06 Throat Acute meningitis
CF199022-07 Feces Acute meningitis
E26 CORONEL Stools None
E27 BACON Stools None
E29 JV10 Stools None
BASTIANNI CSF Acute meningitis
CF1260-78
CF1074-78
CF282-97 Feces Acute meningitis
CF552-00 Feces Acute meningitis
CF2575-00 CSF Acute meningitis
CF220062-05 Throat Acute meningitis
CF307026-07 Throat Acute meningitis
CF284052-07 Throat Acute meningitis
E31 CALDWELL Stools Acute meningitis
E33 CF235069-05 Throat Acute meningitis
EV-B69 TOLUCA1 Rectal swab None
EV-B77 CF496-99 Feces
C CV-A21 CF1069-91
D EV-D70 CF670-71
Clinical features
E7
E13
E3
E4
E6
CV-A2
E11
CV-B1
CV-B2
CV-A4
EV-A71
General features of Enterovirus strains
A
B
E14
CV-B3
CV-B5
E18
E25
E30
CV-B6
E2
